BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36571343)

  • 21. Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16.
    Gardiner M; Sandford A; Deadman M; Poulton J; Cookson W; Reeders S; Jokiaho I; Peltonen L; Eiberg H; Julier C
    Genomics; 1990 Oct; 8(2):387-90. PubMed ID: 2249854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses.
    Kohlschütter A; Schulz A; Bartsch U; Storch S
    CNS Drugs; 2019 Apr; 33(4):315-325. PubMed ID: 30877620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel in-frame mutation in
    Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
    Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis.
    Mole SE; Anderson G; Band HA; Berkovic SF; Cooper JD; Kleine Holthaus SM; McKay TR; Medina DL; Rahim AA; Schulz A; Smith AJ
    Lancet Neurol; 2019 Jan; 18(1):107-116. PubMed ID: 30470609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BATTEN DISEASE CAUSED BY A NOVEL MUTATION IN THE PPT1 GENE.
    Metelitsina TI; Waggoner DJ; Grassi MA
    Retin Cases Brief Rep; 2016; 10(3):211-3. PubMed ID: 26510000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
    Oetjen S; Kuhl D; Hermey G
    J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanisms of juvenile neuronal ceroid lipofuscinosis (JNCL)].
    Wang SY; Jin WN; Wu D
    Yi Chuan; 2009 Aug; 31(8):779-84. PubMed ID: 19689937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
    Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
    J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.
    Rakheja D; Narayan SB; Bennett MJ
    Curr Mol Med; 2007 Sep; 7(6):603-8. PubMed ID: 17896996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.
    Arrant AE; Onyilo VC; Unger DE; Roberson ED
    J Neurosci; 2018 Feb; 38(9):2341-2358. PubMed ID: 29378861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Adams HR; Mink JW;
    J Child Neurol; 2013 Sep; 28(9):1128-36. PubMed ID: 24014508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLN3, at the crossroads of endocytic trafficking.
    Cotman SL; Lefrancois S
    Neurosci Lett; 2021 Sep; 762():136117. PubMed ID: 34274435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins.
    Vesa J; Peltonen L
    Curr Mol Med; 2002 Aug; 2(5):439-44. PubMed ID: 12125809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetic analysis of neuronal ceroid lipofuscinosis.
    Mole SE; Gardiner M
    Int J Neurol; 1991-1992; 25-26():52-9. PubMed ID: 11980063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis.
    Kanninen KM; Grubman A; Caragounis A; Duncan C; Parker SJ; Lidgerwood GE; Volitakis I; Ganio G; Crouch PJ; White AR
    Biol Open; 2013 Jun; 2(6):635-46. PubMed ID: 23789114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.
    Guo J; O'Brien DP; Mhlanga-Mutangadura T; Olby NJ; Taylor JF; Schnabel RD; Katz ML; Johnson GS
    BMC Vet Res; 2015 Jan; 10():960. PubMed ID: 25551667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy.
    Deneubourg C; Ramm M; Smith LJ; Baron O; Singh K; Byrne SC; Duchen MR; Gautel M; Eskelinen EL; Fanto M; Jungbluth H
    Autophagy; 2022 Mar; 18(3):496-517. PubMed ID: 34130600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report.
    Hosseini Bereshneh A; Garshasbi M
    J Med Case Rep; 2018 Sep; 12(1):281. PubMed ID: 30249282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.